The DOI matches its Crossref record.
Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program Evaluation
Abstract
BACKGROUND: The scale-up of antiretroviral treatment (ART) services in resource-limited settings requires a programmatic model to deliver care to large numbers of people. Understanding the determinants of key outcome measures--including death and nondeath losses--would assist in program evaluation and development. METHODS: Between September 2002 and August 2005, all in-program (pretreatment and on-treatment) deaths and nondeath losses were prospectively ascertained among treatment-naive adults (n=1235) who were enrolled in a community-based ART program in South Africa. RESULTS: At study censorship, 927 patients had initiated ART after a median of 34 days after enrollment in the program. One hundred twenty-one (9.8%) patients died. Mortality rates were 33.3 (95% CI, 25.5-43.0), 19.1 (95% CI, 14.4-25.2), and 2.9 (95% CI, 1.8-4.8) deaths/100 person-years in the pretreatment interval, during the first 4 months of ART (early deaths), and after 4 months of ART (late deaths), respectively. Pretreatment and early treatment deaths together accounted for 87% of deaths, and were independently associated with advanced immunodeficiency at enrollment. Late deaths were comparatively few and were only associated with the response to ART at 4 months. Nondeath program losses (loss to follow-up, 2.3%; transfer-out, 1.9%; relocation, 0.7%) were not associated with immune status and were evenly distributed during the study period. CONCLUSIONS: Loss to follow-up and late mortality rates were low, reflecting good cohort retention and treatment response. However, the extremely high pretreatment and early mortality rates indicate that patients are enrolling in ART programs with far too advanced immunodeficiency. Causes of late access to the ART program, such as delays in health care access, health system delays, or inappropriate treatment criteria, need to be addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review
Rosen, S., Fox, M. P., & Gill, C. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040298 · Cited by 796
Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review
Rosen, S., & Fox, M. P. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001056 · Cited by 738
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
Lawn, S. D., Harries, A. D., Anglaret, X., Myer, L., & Wood, R. (2008) · AIDS · doi:10.1097/qad.0b013e32830007cd · Cited by 639
Self-citationGovindasamy, D., Ford, N., & Kranzer, K. (2012) · AIDS · doi:10.1097/qad.0b013e3283578b9b · Cited by 435
Lawn, S. D., Myer, L., Bekker, L.-G., & Wood, R. (2006) · AIDS · doi:10.1097/01.aids.0000238406.93249.cd · Cited by 363
Self-citationLawn, S. D., Myer, L., Bekker, L.-G., & Wood, R. (2007) · AIDS · doi:10.1097/qad.0b013e328011efac · Cited by 343
“Deaths and losses to follow-up were ascertained by active community-based follow-up as described in detail previously [12,13].”
MethodResultSelf-citationLawn, S. D., Myer, L., Edwards, D., Bekker, L.-G., & Wood, R. (2009) · AIDS · doi:10.1097/qad.0b013e32832d3b6d · Cited by 338
Self-citationJarvis, J. N., Lawn, S. D., Vogt, M., Bangani, N., Wood, R., & Harrison, T. S. (2009) · Clinical Infectious Diseases · doi:10.1086/597262 · Cited by 318
Self-citationKranzer, K., Govindasamy, D., Ford, N., Johnston, V., & Lawn, S. D. (2012) · Journal of the International AIDS Society · doi:10.7448/ias.15.2.17383 · Cited by 306
Self-citationDabis, F. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.044248 · Cited by 306
Murdoch, D. M., Venter, W. D., Feldman, C., & Van Rie, A. (2008) · AIDS · doi:10.1097/qad.0b013e3282f4a607 · Cited by 280
Johannessen, A., Naman, E., Ngowi, B. J., Sandvik, L., Matee, M. I., Aglen, H. E., Gundersen, S. G., & Bruun, J. N. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-52 · Cited by 269
Jani, I. V., Sitoe, N. E., Alfai, E. R., Chongo, P. L., Quevedo, J. I., Rocha, B. M., Lehe, J. D., & Peter, T. F. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61052-0 · Cited by 264
The Effect of Tuberculosis on Mortality in HIV Positive People: A Meta-Analysis
Straetemans, M., Bierrenbach, A. L., Nagelkerke, N., Glaziou, P., & van der Werf, M. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015241 · Cited by 68
Parkes‐Ratanshi, R., Achan, B., Kwizera, R., Kambugu, A., Meya, D., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12387 · Cited by 49
Katuramu, R., Kamya, M. R., Sanyu, N., Armstrong-Hough, M., & Semitala, F. C. (2020) · Implementation Science Communications · doi:10.1186/s43058-020-00025-5 · Cited by 9
Metadata
- Authors
- Lawn, S. D., Myer, L., Harling, G., Orrell, C., Bekker, L.-G., & Wood, R.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-09-15
- Volume
- 43
- Issue
- 6
- Pages
- 770-776
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2096254883
- Cited by
- 226
- References
- 0
- FWCI
- 14.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.